Company Announcements

3rd Quarter Results

Source: RNS
RNS Number : 9205O
State Bank Of India
03 February 2023
 

STATE BANK OF INDIA

 

The Listing Department,

BSE Limited,

Phiroje Jeejeebhoy Towers,

25th Floor, Dalal Street,

Mumbai - 400001.

 

The Listing Department,

National Stock Exchange of India Limited,

Exchange Plaza, 5th Floor,

Plot No.: C / 1, 'G' Block,

Bandra Kurla Complex, Bandra (East),

Mumbai - 400051.

 

BSE SCRIP Code: 500112

NSE SCRIP Code: SBIN

 

CC/S&B/SK/2023/723

03.02.2023

 

Madam / Dear Sir,

 

We refer to our letter no.: CC/S&B/SK/2023/710 dated 25.01.2023 intimating about the Meeting of the Central Board of the Bank for considering the financial results of the Bank for the quarter and nine months ended 31st December, 2022.

 

2. In terms of Regulation 33 and Regulation 30 (6) and other applicable regulations of the SEBI (LODR) Regulations, 2015, we forward herewith a copy of the Standalone and Consolidated Financial Results of the Bank approved by the Central Board of the Bank at its Meeting held on 03rd February, 2023 at Mumbai along with the Limited Review Report for the quarter and nine months ended 31st December, 2022.


http://www.rns-pdf.londonstockexchange.com/rns/9205O_1-2023-2-3.pdf

 

3. The Limited Review Report of the Auditors contains unmodified opinion.

 

4. The Central Board Meeting commenced at 01.30 PM and concluded at 03.20 PM.

 

5. The Utilisation Certificate and Statement of Material Deviation on non-convertible debt securities for quarter ended 31.12.2022 as per Regulation 52 (7) and Regulation         52 (7A) of SEBI (LODR) Regulations, 2015 is enclosed herewith.

 

6. The Security Cover Certificate as on 31.12.2022 on non-convertible debt securities in terms of Regulation 54 (3) of SEBI (LODR) Regulations, 2015 is enclosed.

 

Please take the above information on record and arrange for dissemination.

 

Yours faithfully,

 

(Sham K.)

Asst. General Manager (Compliance & Company Secretary)       

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEALADEANDEFA